BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30683835)

  • 1. Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss.
    Gonakoti S; Khullar S; Rajkumar A
    Am J Case Rep; 2019 Jan; 20():111-116. PubMed ID: 30683835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duodenal Villous Atrophy in a TTG-Negative Patient Taking Olmesartan: A Case Report and Review of the Literature.
    Kulai T; Arnason T; MacIntosh D; Igoe J
    Can J Gastroenterol Hepatol; 2016; 2016():6091571. PubMed ID: 27446852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olmesartan-induced enteropathy.
    Onteddu NK; Pulivarthi VSKK; Ginnavaram M; Kedika R
    BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30279248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olmesartan-Induced Enteropathy.
    Adike A; Corral J; Rybnicek D; Sussman D; Shah S; Quigley E
    Methodist Debakey Cardiovasc J; 2016; 12(4):230-232. PubMed ID: 28289500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Three cases of severe chronic diarrhea with a rare cause and a simple therapy].
    Rommel KP; Schneider E; Witschel I; Halm U; Zachäus M
    Internist (Berl); 2018 Sep; 59(9):961-966. PubMed ID: 29637237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Olmesartan-associated enteropathy: attention to an emerging iatrogenic phenomenon].
    Modesto Dos Santos JL; González Recio P; Terry López OA; Leturia Frade I; Aguiar Losada B; Elejalde Guerra JI
    An Sist Sanit Navar; 2017 Aug; 40(2):291-294. PubMed ID: 28676728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe spruelike enteropathy associated with olmesartan.
    Rubio-Tapia A; Herman ML; Ludvigsson JF; Kelly DG; Mangan TF; Wu TT; Murray JA
    Mayo Clin Proc; 2012 Aug; 87(8):732-8. PubMed ID: 22728033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enteropathy due to olmesartan].
    Ould Sidi Mohamed M; Colardelle P
    Ann Cardiol Angeiol (Paris); 2016 Apr; 65(2):95-8. PubMed ID: 26067144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-II inhibitor (olmesartan)-induced collagenous sprue with resolution following discontinuation of drug.
    Nielsen JA; Steephen A; Lewin M
    World J Gastroenterol; 2013 Oct; 19(40):6928-30. PubMed ID: 24187471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe spruelike enteropathy and collagenous colitis caused by olmesartan.
    Kaneko S; Matsuda K; Mizuta Y; Shiratori S; Kishi K; Nakamura A; Yagisawa M; Ehira N; Uebayashi M; Kobayashi H
    BMC Gastroenterol; 2021 Sep; 21(1):350. PubMed ID: 34556042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diarrhoea and malabsorption due to olmesartan use].
    van Beurden YH; Nijeboer P; Janssen J; Verbeek WH; Mulder CJ
    Ned Tijdschr Geneeskd; 2014; 158():A7370. PubMed ID: 24780574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five cases of sprue-like enteropathy in patients treated by olmesartan.
    Théophile H; David XR; Miremont-Salamé G; Haramburu F
    Dig Liver Dis; 2014 May; 46(5):465-9. PubMed ID: 24472297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olmesartan-Associated Enteropathy: A Review of Clinical and Histologic Findings.
    Choi EY; McKenna BJ
    Arch Pathol Lab Med; 2015 Oct; 139(10):1242-7. PubMed ID: 26414468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olmesartan, other antihypertensives, and chronic diarrhea among patients undergoing endoscopic procedures: a case-control study.
    Greywoode R; Braunstein ED; Arguelles-Grande C; Green PH; Lebwohl B
    Mayo Clin Proc; 2014 Sep; 89(9):1239-43. PubMed ID: 25023670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olmesartan: sprue-like enteropathy.
    Prescrire Int; 2014 Apr; 23(148):102. PubMed ID: 24860900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, laboratory, serological, and histological profile of sprue-like enteropathy associated with olmesartan use.
    Sáez González E; Díaz Jaime FC; Del Val Antoñana A
    Rev Esp Enferm Dig; 2016 Oct; 108(10):685-686. PubMed ID: 27109007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review: Sprue-like enteropathy associated with olmesartan.
    Ianiro G; Bibbò S; Montalto M; Ricci R; Gasbarrini A; Cammarota G
    Aliment Pharmacol Ther; 2014 Jul; 40(1):16-23. PubMed ID: 24805127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sprue-like enteropathy linked to olmesartan.
    Campos Ruiz A; Urtasun Arlegui L; Marra-López Valenciano C
    Rev Esp Enferm Dig; 2016 May; 108(5):292-3. PubMed ID: 26925975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new spruelike disease as a cause of severe diarrhea].
    Halevy D; Teeuwen U; Kohlhof P
    Dtsch Med Wochenschr; 2014 Nov; 139(45):2290-3. PubMed ID: 25350242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olmesartan-associated sprue-like enteropathy: a systematic review with emphasis on histopathology.
    Burbure N; Lebwohl B; Arguelles-Grande C; Green PH; Bhagat G; Lagana S
    Hum Pathol; 2016 Apr; 50():127-34. PubMed ID: 26997446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.